A global research priority agenda to advance public health responses to fatty liver diseaseMary E. Rinella, Paul Brennan, Patrizia Burra et al.|Journal of Hepatology|2023Cited by 132
A global action agenda for turning the tide on fatty liver diseaseJeffrey V. Lazarus, Saleh A. Alqahtani, Emmanuel Tsochatzis et al.|Hepatology|2023Cited by 90
Opportunities and challenges following approval of resmetirom for MASH liver diseaseJeffrey V. Lazarus, Paul Brennan, Meena B. Bansal et al.|Nature Medicine|2024Cited by 57